Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Apyx Medical
APYX
$173M
| $45.7K | ﹤0.01% |
+14,284
| New | +$66.6K |
|
|
LOMA
3752
Loma Negra
LOMA
$1.34B
| $45.2K | ﹤0.01% |
7,500
-7,500
| -50% | -$48.3K |
|
3753
ACNB Corp
ACNB
$656M
| $45K | ﹤0.01% |
1,424
-256
| -15% | -$8.48K |
|
|
VCXB.WS
3754
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
| $45K | ﹤0.01% |
250,000
| – | – |
|
3755
Rigel Pharmaceuticals
RIGL
$681M
| $45K | ﹤0.01% |
4,165
-385
| -8% | -$4.63K |
|
|
SHCO
3756
DELISTED
Soho House & Co
SHCO
| $44.7K | ﹤0.01% |
6,455
+1,104
| +21% | +$7.09K |
|
3757
Hyliion Holdings
HYLN
$635M
| $44.6K | ﹤0.01% |
37,810
+8,424
| +29% | +$12.6K |
|
3758
Cato Corp
CATO
$68.3M
| $44.4K | ﹤0.01% |
5,801
+1,827
| +46% | +$14.6K |
|
|
FITE
3759
State Street SPDR S&P Kensho Future Security ETF
FITE
$143M
| $44.3K | ﹤0.01% |
946
| – | – |
|
3760
Park-Ohio Holdings
PKOH
$575M
| $44.3K | ﹤0.01% |
2,225
+547
| +33% | +$10.3K |
|
3761
State Street SPDR S&P Kensho Smart Mobility ETF
HAIL
$18.9M
| $44.2K | ﹤0.01% |
1,430
| – | – |
|
3762
Energy Vault
NRGV
$517M
| $43.8K | ﹤0.01% |
17,183
-2,318
| -12% | -$6.94K |
|
3763
Aura Biosciences
AURA
$725M
| $43.7K | ﹤0.01% |
4,874
-22,978
| -83% | -$247K |
|
3764
Citizens & Northern Corp
CZNC
$456M
| $43.7K | ﹤0.01% |
2,491
-583
| -19% | -$11.3K |
|
|
PVBC
3765
DELISTED
Provident Bancorp
PVBC
| $43.7K | ﹤0.01% |
+4,509
| New | +$42.8K |
|
|
TPIC
3766
DELISTED
TPI Composites
TPIC
| $43.6K | ﹤0.01% |
16,449
+275
| +2% | +$1.68K |
|
3767
iShares MSCI EAFE Value ETF
EFV
$28.8B
| $43.5K | ﹤0.01% |
890
| – | – |
|
3768
Spok Holdings
SPOK
$228M
| $43.4K | ﹤0.01% |
3,044
-508
| -14% | -$6.82K |
|
|
MRSN
3769
DELISTED
Mersana Therapeutics
MRSN
| $43.4K | ﹤0.01% |
1,366
-6,111
| -82% | -$290K |
|
3770
Viemed Healthcare
VMD
$447M
| $43.3K | ﹤0.01% |
6,436
-1,170
| -15% | -$9.59K |
|
3771
Willdan Group
WLDN
$1.04B
| $43.2K | ﹤0.01% |
2,116
-311
| -13% | -$6.59K |
|
3772
Rimini Street
RMNI
$449M
| $43.2K | ﹤0.01% |
19,638
+326
| +2% | +$990 |
|
3773
West Bancorporation
WTBA
$478M
| $43.1K | ﹤0.01% |
2,645
-568
| -18% | -$10.5K |
|
|
PBPB
3774
DELISTED
Potbelly
PBPB
| $43K | ﹤0.01% |
5,512
+283
| +5% | +$2.41K |
|
|
NETI
3775
DELISTED
Eneti Inc.
NETI
| $42.8K | ﹤0.01% |
4,243
-666
| -14% | -$7.67K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.